Progressive retinal atrophy (PRA) is a common inherited eye disease causing gradual and irreversible blindness in dogs. Among its various forms, the rough collie and the smooth collie breeds are particularly affected by the RCD2 variant of PRA. This article explains RCD2 PRA, which dogs it affects, and why testing is essential for maintaining the health of these breeds through responsible breeding.
RCD2, or rod-cone dysplasia type 2, is a form of PRA characterised by the early degeneration of rods and cones—the retina's light- and colour-sensitive cells—leading to rapid vision loss. Unlike other PRA types that may show symptoms from three years onward, RCD2 signs can appear as early as six weeks old, with most affected dogs losing night vision around this time and becoming blind by 6-8 months.
In RCD2, rod cells degenerate faster, causing night blindness first. Eventually, cone cell damage leads to complete blindness.
This early and rapid progression makes understanding RCD2 critical for breeders and owners of affected breeds.
The RCD2 variant specifically affects the rough and smooth collie breeds. Dogs with partial ancestry of these breeds may also carry the gene, potentially passing it on.
This inherited condition manifests early, with puppies typically showing difficulty seeing at night by six weeks old and potentially complete blindness by twelve weeks.
Untested breeding of carriers inadvertently spreads the condition, hence the importance of genetic testing.
RCD2 PRA is an autosomal recessive condition. This means that:
Understanding these inheritance patterns is essential for breeders to avoid producing affected puppies.
Since symptoms of the disease can appear and progress rapidly, affected puppies are typically identified early by owners and breeders and ideally removed from breeding programmes. However, many healthy appearing dogs may be carriers of the faulty gene and unknowingly pass it on if untested.
Genetic testing identifies whether a dog is clear, a carrier, or affected. This information guides breeders in selecting mating pairs responsibly, dramatically reducing the incidence of PRA RCD2 in future generations.
Testing requires a DNA sample, commonly collected via a cheek swab by a vet. This sample is sent to a laboratory specialising in veterinary genetic testing, such as those listed on The Kennel Club's website.
The test uses molecular techniques to detect the presence of the specific gene mutation responsible for RCD2. Results typically come back within one to two weeks and detail the dog's genetic status as clear, carrier, or affected.
To protect the health of rough and smooth collies, breeders should:
Following these steps helps maintain breed vitality and reduces suffering due to blindness.
For more general information about progressive retinal atrophy in dogs, see Progressive Retinal Atrophy (PRA) in Dogs.
If you are looking to find a rough collie puppy or a smooth collie puppy, consider breeders who responsibly test for hereditary conditions like PRA RCD2 to secure a healthy future for your new companion.
Testing and responsible breeding are key to combating this hereditary blindness and preserving the legacy of beloved collie breeds.